Stefan K Plontke
Stefan K Plontke is an expert in Otolaryngology at Martin Luther University Halle-Wittenberg (Germany). As of September 2026, ScienceLeadR ranks Stefan K Plontke in the top 1% of experts worldwide for Hearing Disorders and Hearing Loss. Stefan K Plontke has authored 445 publications, the most recent in 2026, and is an investigator in 6 clinical trials. SLR score: 1,226 (community average: 125). How the SLR is computed.
LeadR Profile
Otolaryngology
Subspecialties: Surgery - Neurology - Oncology
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 1998 - 2026
Number : 445
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Foundation artificial intelligence models enable high-accuracy diagnostic differentiation of hybrid neurofibroma/schwannoma using whole-slide images. PMID 42668461 — neurofibroma, intelligence, workflow, neoplasms, work, foundations, learning, artificial intelligence, landslides, neurilemmoma | J Pathol Inform | 2026 | 0 |
| Preoperative Imaging for Cochlear Implantation: A Global Consensus. PMID 41696991 — magnetic resonance imaging, otolaryngology, diagnostic imaging, surveys and questionnaires, cochlear implants, diagnosis, cochlear implantation, preoperative care | Otolaryngol Head Neck Surg | 2026 | 0 |
| Long-term in vivo pharmacokinetics of dexamethasone-loaded cochlear implant electrode carrier dummies with optimized release profiles. PMID 41656310 — scala tympani, pharmaceutical preparations, dexamethasone, electrodes, hearing, silicones, cochlear implants, natural science disciplines, wounds and injuries, pharmacokinetics | Sci Rep | 2026 | 0 |
| 30-day postoperative mortality and the effects of hospital preparedness during the COVID-19 pandemic: a pooled analysis of prospective international cohort studies. PMID 41648988 — mortality, vaccines, cohort studies, covid-19, pandemics | Lancet Reg Health Eur | 2026 | 0 |
| The Bonebridge BCI 602 Safety and Performance 1 Year Post-Implantation in Adults and Children: A Multicentric Post-Market Study. PMID 41250191 — safety, hearing, drug-related side effects and adverse reactions, speech, child | Otol Neurotol | 2025 | 0 |
Clinical Studies 6
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 3
LeadR Networks
Main global connection map